Search research articles
Contact Us
Filters
Showing results (271-280 of 348) with videos related to
Page
of 35
Sort By:
Frontiers in Immunology
|
September 5, 2022
The relevance of complement in pemphigoid diseases: A critical appraisal
Cristian Papara, Christian M Karsten, Hideyuki Ujiie, et al.
The Journal of Investigative Dermatology
|
March 2, 2013
Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation
Lars Hellberg, Unni K S R L Samavedam, Karoline Holdorf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
August 6, 2025
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series
Kaan Yilmaz, Stephanie Goletz, Christoph M Hammers, et al.
Journal of Cell Science
|
January 3, 2023
Meeting report - Desmosome dysfunction and disease: Alpine desmosome disease meeting
Volker Spindler, Brenda Gerull, Kathleen J Green, et al.
Frontiers in Immunology
|
December 12, 2019
Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus Foliaceus
Luana Caroline Oliveira, Gabriela Canalli Kretzschmar, Andressa Cristina Moraes Dos Santos, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases
Detlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.
Journal of the American Academy of Dermatology
|
November 22, 2023
Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid
Stephanie Goletz, Manuela Pigors, Tina Rastegar Lari, et al.
Experimental Dermatology
|
June 16, 2016
Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology
A Razzaque Ahmed, Marco Carrozzo, Frédéric Caux, et al.
Journal of the American Academy of Dermatology
|
August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
Omar Hasan Ali, David Bomze, Sandra S Ring, et al.
British Journal of Pharmacology
|
August 21, 2020
Identification of novel therapeutic targets for blocking acantholysis in pemphigus
Imke A K Burmester, Sarah Flaswinkel, Clara-Sophie Thies, et al.
Page
of 35
Search research articles
Search
Showing results (271-280 of 348) with videos related to
Sort By:
Page
of 35
Frontiers in Immunology
|
September 5, 2022
The relevance of complement in pemphigoid diseases: A critical appraisal
Cristian Papara, Christian M Karsten, Hideyuki Ujiie, et al.
The Journal of Investigative Dermatology
|
March 2, 2013
Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation
Lars Hellberg, Unni K S R L Samavedam, Karoline Holdorf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
August 6, 2025
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series
Kaan Yilmaz, Stephanie Goletz, Christoph M Hammers, et al.
Journal of Cell Science
|
January 3, 2023
Meeting report - Desmosome dysfunction and disease: Alpine desmosome disease meeting
Volker Spindler, Brenda Gerull, Kathleen J Green, et al.
Frontiers in Immunology
|
December 12, 2019
Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus Foliaceus
Luana Caroline Oliveira, Gabriela Canalli Kretzschmar, Andressa Cristina Moraes Dos Santos, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 4, 2007
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases
Detlef Zillikens, Kurt Derfler, Rüdiger Eming, et al.
Journal of the American Academy of Dermatology
|
November 22, 2023
Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid
Stephanie Goletz, Manuela Pigors, Tina Rastegar Lari, et al.
Experimental Dermatology
|
June 16, 2016
Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology
A Razzaque Ahmed, Marco Carrozzo, Frédéric Caux, et al.
Journal of the American Academy of Dermatology
|
August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors
Omar Hasan Ali, David Bomze, Sandra S Ring, et al.
British Journal of Pharmacology
|
August 21, 2020
Identification of novel therapeutic targets for blocking acantholysis in pemphigus
Imke A K Burmester, Sarah Flaswinkel, Clara-Sophie Thies, et al.
Page
of 35